Chekkera Shammi - Concepedia

Author

Chekkera Shammi

University of Toronto

Also Known As

C Shammi, C. M. Shammi, C.M. Shammi, Chekkera Shammi

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Toronto Centre for Addiction and Mental Health University Health Network

About

Chekkera Shammi is an author at University of Toronto specializing in medicine, social sciences, and psychopharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	386
2	Social Sciences	3	3	375
3	Public Health	1	1	11
4	Epidemiology	1	1	11
5	Hepatology	1	1	11

Chekkera Shammi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study S. Silvestri, Mary V. Seeman, Juan-Carlos Negrete, Psychopharmacology Dopamine D 2PsychiatryMedicinePsychotropic MedicationPsychopharmacology	2000	302
Differential Effects of Aripiprazole on D <sub>2</sub> , 5-HT <sub>2</sub> , and 5-HT <sub>1A</sub> Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study David C. Mamo, Ariel Graff, Romina Mizrahi, American Journal of Psychiatry	2007	241
A PET Study of Dopamine D<sub>2</sub> and Serotonin 5-HT<sub>2</sub> Receptor Occupancy in Patients With Schizophrenia Treated With Therapeutic Doses of Ziprasidone David C. Mamo, Shitij Kapur, Chekkera Shammi, American Journal of Psychiatry	2004	185
A PET Study Evaluating Dopamine D<sub>2</sub> Receptor Occupancy for Long-Acting Injectable Risperidone Gary Remington, David C. Mamo, Alain Labelle, American Journal of Psychiatry	2006	114
The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors Ariel Graff‐Guerrero, David C. Mamo, Chekkera Shammi, Archives of General Psychiatry	2009	99
“Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia Gary Remington, Philip Seeman, Alan Feingold, The Journal of Clinical Psychiatry	2010	67
Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia Hiroyuki Uchida, David C. Mamo, Shitij Kapur, The Journal of Clinical Psychiatry Psychotropic MedicationPsychopharmacologyNeuropsychiatryPharmacotherapySocial Sciences	2008	50
Treatment of Clozapine-Induced Hypersalivation With Ipratropium Bromide Sanjeev Sockalingam, Chekkera Shammi, Gary Remington The Journal of Clinical Psychiatry	2009	29
Antipsychotic Dosing Patterns for Schizophrenia in Three Treatment Settings Gary Remington, Chekkera Shammi, Rustom Sethna, Psychiatric Services PsychiatryPsychotic DisorderMedicineDaily DosagesPsychotropic Medication	2001	23
Does nicotine affect D2 receptor upregulation? A case–control study S. Silvestri, Juan-Carlos Negrete, Mary V. Seeman, Acta Psychiatrica Scandinavica	2004	17

Page 1